163 related articles for article (PubMed ID: 3095471)
1. Chromium 51-ethylenediaminetetraacetate test: a useful test in the assessment of inflammatory bowel disease.
O'Morain CA; Abelow AC; Chervu LR; Fleischner GM; Das KM
J Lab Clin Med; 1986 Nov; 108(5):430-5. PubMed ID: 3095471
[TBL] [Abstract][Full Text] [Related]
2. Comparison between lactulose-mannitol test and 51Cr-labelled ethylene diamine tetra-acetate test in inflammatory bowel diseases.
Andre C; Descos L; Minaire Y
Hepatogastroenterology; 1990 Dec; 37 Suppl 2():113-7. PubMed ID: 2128072
[TBL] [Abstract][Full Text] [Related]
3. Intestinal permeability to [51Cr]EDTA in children with Crohn's disease and celiac disease.
Turck D; Ythier H; Maquet E; Deveaux M; Marchandise X; Farriaux JP; Fontaine G
J Pediatr Gastroenterol Nutr; 1987; 6(4):535-7. PubMed ID: 3123634
[TBL] [Abstract][Full Text] [Related]
4. Measurement of intestinal permeability using 51Cr-EDTA.
Peled Y; Watz C; Gilat T
Am J Gastroenterol; 1985 Oct; 80(10):770-3. PubMed ID: 3929593
[TBL] [Abstract][Full Text] [Related]
5. Comparison of different measurements of intestinal permeability in inflammatory bowel disease.
Howden CW; Robertson C; Duncan A; Morris AJ; Russell RI
Am J Gastroenterol; 1991 Oct; 86(10):1445-9. PubMed ID: 1928036
[TBL] [Abstract][Full Text] [Related]
6. Intestinal permeability compared in pediatric and adult patients with inflammatory bowel disease.
Issenman RM; Jenkins RT; Radoja C
Clin Invest Med; 1993 Jun; 16(3):187-96. PubMed ID: 8365046
[TBL] [Abstract][Full Text] [Related]
7. Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease.
Bjarnason I; O'Morain C; Levi AJ; Peters TJ
Gastroenterology; 1983 Aug; 85(2):318-22. PubMed ID: 6407889
[TBL] [Abstract][Full Text] [Related]
8. Intestinal permeability of 51Cr-labelled ethylenediaminetetraacetic acid in patients with Crohn's disease and their healthy relatives.
Ainsworth M; Eriksen J; Rasmussen JW; Schaffalitzky de Muckadell OB
Scand J Gastroenterol; 1989 Oct; 24(8):993-8. PubMed ID: 2512633
[TBL] [Abstract][Full Text] [Related]
9. Small bowel and colonic permeability to 51Cr-EDTA in patients with active inflammatory bowel disease.
Jenkins RT; Ramage JK; Jones DB; Collins SM; Goodacre RL; Hunt RH
Clin Invest Med; 1988 Apr; 11(2):151-5. PubMed ID: 3135136
[TBL] [Abstract][Full Text] [Related]
10. Fecal radioiodide excretion following intravenous injection of 131-I-albumin and 125-I-immunoglobulin G in chronic inflammatory bowel disease. An aid to topographic diagnosis.
Jarnum S; Jensen KB
Gastroenterology; 1975 Jun; 68(6):1433-44. PubMed ID: 1132626
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous administration of lactulose and 51Cr-ethylenediaminetetraacetic acid. A test to distinguish colonic from small-intestinal permeability change.
Jenkins AP; Nukajam WS; Menzies IS; Creamer B
Scand J Gastroenterol; 1992 Sep; 27(9):769-73. PubMed ID: 1411284
[TBL] [Abstract][Full Text] [Related]
12. 51Cr-EDTA/14C-mannitol intestinal permeability test. Clinical use in screening for coeliac disease.
Fotherby KJ; Wraight EP; Neale G
Scand J Gastroenterol; 1988 Mar; 23(2):171-7. PubMed ID: 3129775
[TBL] [Abstract][Full Text] [Related]
13. Effects of smoking on the urine excretion of oral 51Cr EDTA in ulcerative colitis.
Benoni C; Prytz H
Gut; 1998 May; 42(5):656-8. PubMed ID: 9659159
[TBL] [Abstract][Full Text] [Related]
14. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
Pimentel M; Chang M; Chow EJ; Tabibzadeh S; Kirit-Kiriak V; Targan SR; Lin HC
Am J Gastroenterol; 2000 Dec; 95(12):3458-62. PubMed ID: 11151877
[TBL] [Abstract][Full Text] [Related]
15. Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases.
Jenkins RT; Jones DB; Goodacre RL; Collins SM; Coates G; Hunt RH; Bienenstock J
Am J Gastroenterol; 1987 Nov; 82(11):1159-64. PubMed ID: 3118697
[TBL] [Abstract][Full Text] [Related]
16. Absorption of 51Cr-EDTA in ulcerative colitis following rectal instillation.
Rask-Madsen J; Schwartz M
Scand J Gastroenterol; 1970; 5(5):361-8. PubMed ID: 4989516
[No Abstract] [Full Text] [Related]
17. Time course of gastrointestinal tract permeability to chromium 51-labeled ethylenediaminetetraacetate in healthy dogs.
Marks SL; Williams DA
Am J Vet Res; 1998 Sep; 59(9):1113-5. PubMed ID: 9736386
[TBL] [Abstract][Full Text] [Related]
18. Location and activity of ulcerative and Crohn's colitis by indium 111 leukocyte scan. A prospective comparison study.
Stein DT; Gray GM; Gregory PB; Anderson M; Goodwin DA; McDougall IR
Gastroenterology; 1983 Feb; 84(2):388-93. PubMed ID: 6848412
[TBL] [Abstract][Full Text] [Related]
19. Urinary patterns of patients with renal stones associated with chronic inflammatory bowel disease.
Trinchieri A; Lizzano R; Castelnuovo C; Zanetti G; Pisani E
Arch Ital Urol Androl; 2002 Jun; 74(2):61-4. PubMed ID: 12161938
[TBL] [Abstract][Full Text] [Related]
20. Intestinal permeability in patients with Crohn's disease and their first-degree relatives.
Howden CW; Gillanders I; Morris AJ; Duncan A; Danesh B; Russell RI
Am J Gastroenterol; 1994 Aug; 89(8):1175-6. PubMed ID: 8053430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
